Research Topic: Medicinal

Decursin, Identified via High-Throughput Chemical Screening, Enhances Plant Disease Resistance via Two Independent Mechanisms

Researchers identified a natural compound called decursin from angelica plants that helps plants fight off dangerous fungal infections in two ways: it strengthens the plant’s own immune system and directly kills the fungal pathogens. This dual-action approach makes decursin a promising natural alternative to synthetic fungicides for protecting crops like wheat and tomatoes from diseases. The compound shows particular promise because it comes from plants, breaks down easily in the environment, and is more effective than other natural antimicrobial compounds currently used in agriculture.

Read More »

Effects of classical psychedelics on implicit and explicit emotional empathy and cognitive empathy: a meta-analysis of MET task

This study compiled data from multiple research studies to understand how classical psychedelics like LSD, psilocybin, and ayahuasca affect empathy—the ability to understand and share others’ feelings. The findings show these substances significantly increase emotional empathy, helping people feel more connected to others’ emotions. However, they don’t appear to affect cognitive empathy, which is the mental ability to understand what others are thinking. These results suggest psychedelics may have therapeutic potential for improving social connection and emotional understanding.

Read More »

Cwh8 moonlights as a farnesyl pyrophosphate phosphatase and is essential for farnesol biosynthesis in Candida albicans

Candida albicans is a common fungus that causes serious infections in people with weakened immune systems. The fungus produces a molecule called farnesol that prevents it from growing in long filaments, which are associated with virulence. Researchers discovered that an enzyme called Cwh8 is absolutely essential for making farnesol, and when this enzyme is missing, the fungus becomes highly sensitive to the antifungal drug fluconazole, suggesting a potential strategy to overcome drug resistance.

Read More »

Clinically proven natural products against breast cancer, with mechanistic insights

This comprehensive review examines ten natural products that have been proven in clinical studies to help fight breast cancer. These products—including omega-3 fatty acids from fish, compounds in broccoli sprouts, garlic, soy, curcumin from turmeric, and green tea—work by triggering cancer cells to self-destruct, stopping their growth, and preventing blood vessel formation that feeds tumors. What makes these findings especially promising is that these natural products appear to work well alongside conventional treatments while causing minimal side effects, offering patients additional options for managing this serious disease.

Read More »

Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review

This review examines two emerging psychiatric treatments—ketamine and psilocybin—for treating hard-to-treat mental health conditions in children and teenagers. Both work by affecting brain chemicals differently than traditional medications and can provide rapid symptom relief, sometimes within hours or days rather than weeks. The study found promising results for depression, anxiety, PTSD, and bipolar disorder, though researchers emphasize that more studies are needed to ensure these treatments are safe for developing brains and that careful ethical guidelines must be established.

Read More »

Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis

This comprehensive analysis of 10 clinical trials shows that psilocybin, a compound from magic mushrooms, can rapidly reduce depression symptoms starting within one day of administration and maintain these benefits for up to 6 months. Higher doses and two treatment sessions produced better results than single lower doses. While psilocybin did raise blood pressure temporarily, it was generally well-tolerated with dropout rates similar to placebo.

Read More »

A sense of the bigger picture: A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use

This research explored how 15 people with bipolar disorder who used psilocybin mushrooms experienced the effects. Many reported benefits like reduced depression and improved outlook on life, but some experienced negative effects including sleep problems and increased manic episodes. The study identified important factors that influenced outcomes, such as whether people used other drugs simultaneously, whether they used psilocybin alone or with others, and how much sleep they had before use. The researchers concluded that while psilocybin shows promise for bipolar depression, more careful clinical research is needed to ensure safety.

Read More »

An Overview of Physiologically-Based Pharmacokinetic Models for Forensic Science

This review examines how mathematical models that predict how drugs and chemicals move through the body could be better used in forensic science to help explain cause of death and interpret toxicology evidence. Currently, only a few such models have been specifically developed for forensic purposes, though many exist for common drugs like opioids, cocaine, and alcohol. A major challenge is accounting for how drug concentrations change after death, which can make it harder to determine what the concentration was when the person died.

Read More »

How Do Cyclodextrins and Dextrans Affect the Gut Microbiome? Review of Prebiotic Activity

Cyclodextrins and dextrans are substances commonly used in medicines that may have unexpected health benefits for your gut bacteria. Research shows these compounds can help beneficial bacteria like Lactobacillus and Bifidobacterium grow better in your digestive system. When these good bacteria ferment these substances, they produce helpful compounds called short-chain fatty acids that improve overall gut health and may help with conditions like obesity and inflammation.

Read More »

Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential

Psychedelic drugs like LSD and psilocybin are substances that alter perception and consciousness. Research shows they may help treat serious mental health conditions including depression, anxiety, and PTSD by affecting how the brain forms new connections. These substances are relatively safe compared to many legal drugs, and scientists believe they could revolutionize mental health treatment when used properly under medical supervision.

Read More »
Scroll to Top